AbbVie scientists and Steve Davidsen, Vice President, Oncology Discovery, celebrate the invention of new molecules for cancer research with a “molecule hanging ceremony.”
Break new ground
Our R&D is breaking new ground in complex disease areas like immunology, oncology, neurology, virology and more. And our regulatory team safeguards the trust placed in AbbVie by ensuring our products and practices adhere to the highest standards.
Our Research & Development roles
- Analytical Research & Development
- Data & statistical sciences (DSS)
- Discovery
- Global medical affairs
- Pharmaceutical development
- Pharmacovigilance
- Pharmacology
- Quality assurance
- Chemistry, manufacturing & controls (CMC)
- Global labeling, advertising & promotion
- Global product strategy
- Regulatory operations, policy & intelligence
In their own words
“When all the laboratory work and meetings and tests and benchmarks and moments of doubt and joy and clinical trials are all accomplished, and we can finally get medicine into the hands of people who have waited for it to improve their quality of life—that represents the ‘why’.”
– Betty Yao, Scientific Director
Betty focuses on hepatitis C research, working to bring new therapy to patients. She was inducted into the AbbVie Community of Science in 2009, which recognizes outstanding scientific achievements in the research and development organization. Watch Betty’s story to learn more about her journey as a scientist.
